Repligen (RGEN) Other Accumulated Expenses (2011 - 2026)

Repligen (RGEN) has 15 years of Other Accumulated Expenses data on file, last reported at $19.8 million in Q1 2026.

• On a quarterly basis, Other Accumulated Expenses fell 9.7% year-over-year to $19.8 million in Q1 2026; TTM through Mar 2026 was $19.8 million, a 9.7% decrease from a year earlier, with the FY2025 full-year figure at $20.9 million, up 33.81% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $19.8 million, down from $20.9 million in the prior quarter.
• Over the last five years, Other Accumulated Expenses for RGEN reached as high as $22.7 million in Q3 2025 and fell as low as $14.7 million in Q2 2023.
• Historically, Other Accumulated Expenses has averaged $17.8 million across 5 years, with a median of $16.8 million in 2023.
• Across the five-year window, Other Accumulated Expenses soared 1090.58% in 2022 and fell 13.08% in 2023, its largest moves.
• Year by year, Other Accumulated Expenses stood at $15.9 million in 2022, then gained by 5.78% to $16.8 million in 2023, then declined by 7.02% to $15.6 million in 2024, then soared by 33.81% to $20.9 million in 2025, then retreated by 5.24% to $19.8 million in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $19.8 million in Q1 2026, $20.9 million in Q4 2025, and $22.7 million in Q3 2025.